NEO Comptes : Analyse IA Neogenomics Inc

Accueil

Stock

NEO

NEO Financier

Neogenomics Inc

$11.38

1.88%

$0.21

À la fermeture : Feb 13, 16:00:00 GMT-5

$11.38

Post-Marché: Feb 13, 20:00:00 GMT-5

Aperçu Prévision Gagner Dividendes Comptes financiers

Revenus

État de situation

Flux de trésorerie

Annuel

Trimestriellement

NEO Revenu

Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenus	709	660	591	509	484	444
Croissance des revenus (H/H)	10%	12%	16%	5%	9%	9%
Coût des ventes	400	370	347	321	297	258
Bénéfice brut	308	290	244	187	187	185
Vente, Général et Administration	351	310	279	277	229	169
Recherche et développement	35	29	25	28	21	8
Frais d'exploitation	400	375	341	341	290	197
Autres revenus (charges) non opérationnels	0	0	0	0	0	11
Bénéfice avant impôts	-113	-80	-97	-159	-15	-14
Charge d'impôt sur le revenu	0	-1	-9	-15	-6	-18
Bénéfice net	-113	-78	-87	-144	-8	4
Croissance du bénéfice net	47%	-10%	-40%	1,700%	-300%	-50%
Actions en circulation (diluées)	128.41	126.65	125.5	124.2	120	111.8
Variation des actions (H-H)	1%	1%	1%	4%	7%	8%
EPS (dilué)	-0.88	-0.62	-0.7	-1.16	-0.07	0.04
Croissance du EPS	44%	-11%	-40%	1,557%	-275%	-50%
Flux de trésorerie libre	-17	-34	-30	-96	-90	-27
Flux de trésorerie libre par action	--	--	--	--	--	--
Marge brute	43.44%	43.93%	41.28%	36.73%	38.63%	41.66%
Marge opérationnelle	-12.97%	-12.87%	-16.24%	-30.05%	-21.28%	-2.47%
Marge bénéficiaire	-15.93%	-11.81%	-14.72%	-28.29%	-1.65%	0.9%
Marge du flux de trésorerie libre	-2.39%	-5.15%	-5.07%	-18.86%	-18.59%	-6.08%
EBITDA	-79	-50	-60	-119	-64	9
Marge EBITDA	-11.14%	-7.57%	-10.15%	-23.37%	-13.22%	2.02%
D&A pour le résultat opérationnel	13	35	36	34	39	20
EBIT	-92	-85	-96	-153	-103	-11
Marge EBIT	-12.97%	-12.87%	-16.24%	-30.05%	-21.28%	-2.47%
Taux d'imposition effectif	0%	1.25%	9.27%	9.43%	40%	128.57%

Statistiques clés

Clôture préc.

$11.17

Prix d'ouverture

$11.32

Plage de la journée

$11.16 - $11.61

Plage de 52 semaines

$4.72 - $14.73

Volume

2.6M

Volume moyen

1.8M

BPA (TTM)

-0.89

Rendement en dividend

Capitalisation boursière

$1.4B

Qu’est-ce que NEO ?

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company is headquartered in Fort Myers, Florida and currently employs 2,200 full-time employees. The company went IPO on 2012-12-10. The firm offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing; interpretation and consultative services; molecular and NGS testing; comprehensive technical and professional services offering; clinical trials and research; validation laboratory services, and oncology data solutions. The company operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics (karyotype analysis), Fluorescence In-Situ Hybridization (FISH), Flow cytometry, and others.



Fonctionnalités

Copilote IA pour actions et cryptomonnaies

Prédiction des prix

Suivi des collectes de fonds

Thèmes

Comparaison de cryptomonnaies

Ressources